Partial
Mostly Aligned
Patient Risk:
Low
Summary
The claims align with core Lipitor label concepts (indication, mechanism, and some adverse reactions) but include multiple unsupported statements about orange juice-drug interactions and omit important population safety information (pregnancy and pediatric use). Overall, partial alignment with notable safety information omissions and non-label interaction claims.
Category Scores
Accurate Statements
Lipitor, also known as atorvastatin, is a statin medication used to lower cholesterol levels and prevent cardiovascular disease.
Label 1; 12.1
It works by inhibiting the production of cholesterol in the liver, thereby reducing LDL.
Label 12.1
Potential adverse effects include muscle damage (myopathy).
Label 6; 5.1
Potential adverse effects include liver damage (hepatotoxicity).
Label 6; 5.2
Unsupported Statements
Orange juice contains a compound called furanocoumarin.
Not present in label; no mention of furanocoumarins in the provided labeling.
Furanocoumarins are a class of compounds that can inhibit the activity of certain enzymes, including the cytochrome P450 enzyme system.
Not present in label.
When you consume orange juice, the furanocoumarins in the juice can bind to the cytochrome P450 enzyme system, reducing its activity.
Not present in label.
This can lead to increased levels of Lipitor in the bloodstream.
Not present in label.
The interaction between orange juice and atorvastatin may be clinically significant, particularly in patients with renal impairment.
Not present in label.
The interaction can occur within 2 hours of consuming orange juice and taking Lipitor.
Not present in label.
Avoid consuming orange juice within 2 hours of taking Lipitor.
Not present in label.
Taking Lipitor with beverages such as water or milk can minimize the risk of interaction.
Not present in label.
Symptoms of an interaction may include muscle damage, liver damage, and kidney damage.
While some symptoms align with adverse effects, the specific interaction claims are not in the label.
It is generally recommended to avoid consuming orange juice within 2 hours of taking Lipitor.
Not present in label.
Contradictions
Important Omissions
Pregnancy risk: Atorvastatin is contraindicated in pregnancy and should be avoided by women who are pregnant or may become pregnant; it may cause fetal harm (8.1).
Importance:
High
Pediatric safety: Safety and efficacy in pediatric patients have limitations; safety in younger children has not been established (8.4).
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
Major safety claims (myopathy, hepatotoxicity) are supported but several non-label claims about orange juice interactions are unsupported; omissions concern pregnancy and pediatric safety but do not indicate immediate patient danger beyond misinformation risk.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Non-label orange juice interaction claims and omission of critical population safety information (pregnancy and pediatric use).
Suggested Improvement
Limit statements to label-supported information; remove orange juice interaction claims; include pregnancy contraindication (8.1) and pediatric safety details (8.4) as appropriate; add any relevant monitoring/precautions as per label.